Since previous studies showed that one of the mechanisms involved in calcitriol anticancer effects in breast cancer was its ability to inhibit EAG1 expression[9, 17], we explored whether this process could also be taking place in our in vivo model. The gene discussed is KCNH1; the disease is breast carcinoma.